Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane‐associated tumor necrosis factor α

Open Access
Publisher Website
Google Scholar
Abstract
Objective: In systemic sclerosis (SSc; scleroderma), T cells infiltrate organs undergoing fibrotic changes and may participate in dysregulated production of collagen by fibroblasts. The objective of this study was to functionally characterize T cells infiltrating skin lesions in early SSc and investigate their capacity to affect production of type I collagen and interstitial collagenase (matrix metalloproteinase 1 [MMP‐1]) by dermal fibroblasts.Methods: Four‐color cytometric analysis was used to characterize subset distribution and production of interferon‐γ (IFNγ) and interleukin‐4 (IL‐4) in T cell lines generated from the skin of patients with SSc. T cell clones were generated, and their capacity to modulate collagen and MMP‐1 production by fibroblasts derived from patients with SSc and from normal individuals was assessed. Neutralizing reagents were used to identify T cell mediators involved in fibroblast modulation.Results: The skin of individuals with early‐stage SSc contained T cells preferentially producing high levels of IL‐4. Cloned CD4+ Th2‐like cells inhibited collagen production by normal fibroblasts. Th2 cell‐dependent inhibition was, at least in part, contact‐dependent, was essentially mediated by tumor necrosis factor α (TNFα), and was dominant over the enhancement induced by profibrotic IL‐4 and transforming growth factor β cytokines. The simultaneous induction of MMP‐1 production confirmed the specificity of these observations. To be inhibitory, Th2 cells required activation by CD3 ligation. Th2 cells were less potent than were Th1 cells in inhibiting collagen production by normal fibroblasts via cell‐to‐cell interaction, and SSc fibroblasts were resistant to inhibition.Conclusion: These findings indicate that, despite their production of IL‐4, Th2 cells reduce type I collagen synthesis by dermal fibroblasts because of the dominant effect of TNFα, and suggest that strategies based on TNFα blockade aimed at controlling fibrosis in SSc may be unwise.
Funding Information
  • Swiss National Science Foundation (3100-058558.99/1, 3100-100478)
  • Association des Sclérodermiques de France
  • Hans Wilsdorf Foundation
  • Rheumatikerförbundet and King Gustaf V Foundation

This publication has 48 references indexed in Scilit: